Third Time's The Charm: Outlook Therapeutics' Lytenava Heads To FDA, Again

Outlook Therapeutics faces a pivotal FDA decision for Lytenava on December 31st, following two prior rejections. Read why ...

The Democratic split over whether to befriend AI — or vilify it

That includes everyone from traditional populists such as Sen. Bernie Sanders (I-Vt.), to Democrats with a bone to pick with ...
BMJ Open

Enhancing the use of economic evidence in vaccination policy and decision making in low- and middle-income countries: a scoping review of existing strategies

Objectives The use of economic evidence to prioritise vaccines and delivery strategies to optimally use in immunisation systems is becoming a global priority, especially in low- and middle-income ...
FODMAP Everyday® on MSN

How long COVID may be affecting your gut health

Third in a series of articles on COVID-19 and its effects on the gut, this article will explore “Long COVID” (also called ...